Mallinckrodt Executive Summary

482 Words1 Page

The level of organizational maturity at Mallinckrodt Pharmaceuticals is well above average, i.e. a 7 out of 10. For a company closing up on its 150 years anniversary, Mallinckrodt has gone through a lot of mergers and acquisition in the past century, which makes it difficult to gauge their maturity accurately as a stand-alone entity.
The organization structure is designed in the vertical form where positions are categorized as top manager, mid-level manager, first-line manager, and operations personnel to allow for proper reporting channel and unity of command.
At the corporate level, there is the,
CEO – Chief executive officer and head of the organization.
SVP – Senior Vice President and executive president of major functional areas. They …show more content…

Using the stages of organization maturity model, Mallinckrodt Pharmaceuticals falls in the Strategic category. Since their most recent spin-off from former-parent company, Covidien LLC. The company has re-aligned itself in the pharmaceutical market to further strengthen themselves as a specialty generic manufacturer and as a brand pharmaceutical manufacturer by multiple acquisitions of companies such as Therakos, Questcor, Ikaria, Cadence, CNS, and Stratatech Pharmaceuticals. In addition, they have spun-off some other section of the company “Imaging API” to Guebert and Curium Pharmaceuticals.
The strategic alignment journey has been bolstered by the solidity of the Performance Excellence business group within the company and embedded in every business unit to help ensure they all are aligned with the overall organizational goal. They have been able to use tools such as the huddle to foster communication of leading and lagging metrics indicator to stay aligned, disciplined, predict/forecast an issue, and visually manage using high quantitative data on a day-to-day

Open Document